Answer
Its UK licence covers locally advanced or metastatic non-small-cell lung cancer other than predominantly squamous histology, reflecting the populations in which benefit was established.
Sources for this answer
- Pemetrexed 25 mg/ml concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.